<DOC>
	<DOCNO>NCT00179803</DOCNO>
	<brief_summary>The primary goal study determine stem cell transplant patient newly diagnose high risk CNS tumor ( glioblastoma multiforme [ GBM ] , high grade astrocytoma , pineoblastoma , rhabdoid tumor , supratentorial primitive neuroectodermal tumor [ PNET ] ) increase overall survival .</brief_summary>
	<brief_title>Stem Cell Transplant High Risk Central Nervous System ( CNS ) Tumors</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Rhabdoid Tumor</mesh_term>
	<mesh_term>Pinealoma</mesh_term>
	<mesh_term>Supratentorial Neoplasms</mesh_term>
	<criteria>Patient 's age must great ( &gt; ) 18 month less equal ( â‰¤ ) 25 year time diagnosis recurrence . Neuroradiographic evidence recurrent posterior fossa medulloblastoma recurrent CNS germ cell tumor . The presence histologically confirm high grade astrocytoma , GBM , rhabdoid tumor , supratentorial PNET , pineoblastoma either time diagnosis recurrence . Patients must bring state minimum residual disease surgical reduction and/or chemotherapy and/or radiation therapy combination prior myeloablative chemotherapy tandem stem cell rescue . Documentation chemotherapy sensitivity require enrollment . Chemotherapysensitive tumor define tumor reduction 50 % 24 cycle chemotherapy ( CTX platinum ) . For patient evidence disease post resection , continue complete remission 24 cycle chemotherapy defines chemosensitivity . Adequate physiologic function , define follow : creatinine clearance &gt; 70 ml/minutes/1.73 m2 . SGPT &lt; 10 x normal bilirubin &lt; 10 mg/dl . Adequate complete blood count ( CBC ) : hemoglobin &gt; 10 gm/dl , absolute neutrophil count ( ANC ) &gt; 1500/ul , platelet &gt; 100,000/ul . Informed consent . The patient and/or patient 's legally authorized guardian must acknowledge write consent become study subject obtain , accordance institutional policy provide United States ( U.S. ) Department Health Human Services . Protocol approval . Approval use institution 's Human Rights Committee must obtain accordance institutional assurance policy U. S. Department Health Human Services . Patients highrisk medulloblastoma initial surgery . To allow nonEnglish speaking patient participate study , bilingual health care service provide appropriate language . Patients brain stem glioma ineligible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>brain tumor</keyword>
	<keyword>medulloblastoma</keyword>
	<keyword>germ cell tumor</keyword>
	<keyword>CNS tumor</keyword>
	<keyword>glioblastoma</keyword>
	<keyword>astrocytoma</keyword>
	<keyword>pineoblastoma</keyword>
	<keyword>rhabdoid tumor</keyword>
	<keyword>supratentorial PNET</keyword>
	<keyword>high grade astrocytoma</keyword>
</DOC>